Search

everythinglearnresearchcommunity

for

Search:↓

The oral testosterone effectively increased testosterone levels and reduced SHBG, showing promise for treating testosterone deficiency.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

SHBG may be a useful early indicator and treatment target for PCOS.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Women aged 21-26 have a higher rate of PCOS.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

DHT may increase the risk of heart disease and death in elderly men.

Lower SHBG levels may increase the risk of PCOS.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.